Literature DB >> 20097253

Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.

Andrea Contestabile1, Fabio Benfenati, Laura Gasparini.   

Abstract

Down syndrome (DS) is the leading cause of genetically-defined intellectual disability and congenital birth defects. Despite being one of the first genetic diseases identified, only recently, thanks to the phenotypic analysis of DS mouse genetic models, we have begun to understand how trisomy may impact cognitive function. Cognitive disabilities in DS appear to result mainly from two pathological processes: neurogenesis impairment and Alzheimer-like degeneration. In DS brain, suboptimal network architecture and altered synaptic communication arising from neurodevelopmental impairment are key determinants of cognitive defects. Hypocellularity and hypoplasia start at early developmental stages and likely depend upon impaired proliferation of neuronal precursors, resulting in reduction of numbers of neurons and synaptic contacts. The impairment of neuronal precursor proliferation extends to adult neurogenesis and may affect learning and memory. Neurodegenerative mechanisms also contribute to DS cognitive impairment. Early onset Alzheimer disease occurs with extremely high incidence in DS patients and is causally-related to overexpression of beta-amyloid precursor protein (betaAPP), which is one of the triplicated genes in DS. In this review, we will survey the available findings on neurodevelopmental and neurodegenerative changes occurring in DS throughout life. Moreover, we will discuss the potential mechanisms by which defects in neurogenesis and neurodegenerative processes lead to altered formation of neural circuits and impair cognitive function, in connection with findings on pharmacological treatments of potential benefit for DS. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20097253     DOI: 10.1016/j.pneurobio.2010.01.003

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  36 in total

1.  Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?

Authors:  Bin Yu; Jing Kong; Baoling Xing; Ziqiang Zhu; Bin Zhang; Qiu-Wei Wang; Shi-He Shao
Journal:  Neurol Sci       Date:  2013-11-17       Impact factor: 3.307

2.  Age- and speed-dependent modulation of gaits in DSCAM2J mutant mice.

Authors:  Louise Thiry; Maxime Lemieux; Frédéric Bretzner
Journal:  J Neurophysiol       Date:  2017-11-01       Impact factor: 2.714

3.  Family Sense-Making After a Down Syndrome Diagnosis.

Authors:  Lauren Clark; Heather E Canary; Kyle McDougle; Rebekah Perkins; Ruth Tadesse; Avery E Holton
Journal:  Qual Health Res       Date:  2020-07-03

4.  Whether Alzheimer's diseases related genes also differently express in the hippocampus of Ts65Dn mice?

Authors:  Bin Zhang; Qiuwei Wang; Tingting Miao; Bin Yu; Pei Yuan; Jing Kong; Beiyi Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Mehrdad Faizi; Lucia F Jacobs; Khin Htun; Mehrdad Shamloo; William C Mobley
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

6.  Lithium rescues synaptic plasticity and memory in Down syndrome mice.

Authors:  Andrea Contestabile; Barbara Greco; Diego Ghezzi; Valter Tucci; Fabio Benfenati; Laura Gasparini
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 7.  The impact of sleep problems on functional and cognitive outcomes in children with Down syndrome: a review of the literature.

Authors:  Jasneek K Chawla; Scott Burgess; Helen Heussler
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

8.  A human stem cell model of early Alzheimer's disease pathology in Down syndrome.

Authors:  Yichen Shi; Peter Kirwan; James Smith; Glenn MacLean; Stuart H Orkin; Frederick J Livesey
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

9.  The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.

Authors:  Arnaud Duchon; Stéphanie Pothion; Véronique Brault; Andrew J Sharp; Victor L J Tybulewicz; Elizabeth M C Fisher; Yann Herault
Journal:  Behav Brain Res       Date:  2010-10-31       Impact factor: 3.332

10.  Developmental patterns of DR6 in normal human hippocampus and in Down syndrome.

Authors:  Anand Iyer; Jackelien van Scheppingen; Jasper Anink; Ivan Milenkovic; Gabor G Kovács; Eleonora Aronica
Journal:  J Neurodev Disord       Date:  2013-04-24       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.